Nonlethal or chronic low doses of digitoxin, digoxin and ouabain inhibit the expression of the PSA gene by altering PDEF gene expression in human prostate cancer cell lines (LNCaP) [55]. The gene discussed is SPDEF; the disease is prostate carcinoma.